CASE RESULTS DEPEND UPON A VARIETY OF FACTORS UNIQUE TO EACH CASE. THEY DO NOT GUARANTEE OR PREDICT A SIMILAR RESULT IN ANY FUTURE CASE. SETTLEMENTS BELOW REPRESENT TOTAL GOVERNMENT RECOVERIES IN CASES WHERE THERE WERE OFTEN MORE THAN ONE RELATOR ENTITLED TO A PORTION OF RECOVERY.
$2.3B
We represented one of several relators in the 2009 recovery against Pfizer that was one of the largest False Claims Act recoveries in the nation’s history. When our client came to the firm, she was seriously considering accepting a severance package worth approximately $40,000. We advised our client to forego accepting the severance package, and instead to bring a claim under the False Claims Act. As a result, she received a very significant seven figure whistleblower award and helped put an end to the fraud.
Read More: https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history
$1.4B
We represented a whistleblower in a recovery against Reckitt Benckiser Group PLC and Reckitt Benckiser LLC (collectively “Reckitt”), wherein in 2019 the companies agreed to pay $1.4 billion to resolve allegations made by the United State DOJ, the FCC, and several whistleblower lawsuits that Reckitt defrauded Medicare, Medicaid and other government funded healthcare programs in connection with its marketing practices for Suboxone tablet and Suboxone film, both of which are opioid dependence treatment regimens.
Read More: https://www.justice.gov/opa/pr/justice-department-obtains-14-billion-reckitt-benckiser-group-largest-recovery-case
$600M
We represented a whistleblower against Indivior Inc., wherein in 2020 the company agreed to pay a total of $600 million to the government to resolve criminal and civil liability associated with the marketing of the opioid-addiction-treatment drug Suboxone. $300 million of the settlement was paid to resolve the civil claims that the marketing of Suboxone caused false claims to be submitted to government health care programs.
Read More:
https://www.justice.gov/opa/pr/indivior-solutions-pleads-guilty-felony-charge-and-indivior-entities-agree-pay-600-million
$48M
We represented a whistleblower in the 2019 recovery against Encompass Health Corporation (formerly known as HealthSouth Corporation), the nation’s largest operator of inpatient rehabilitation facilities (IRFs), wherein they agreed to pay $48 million to resolve allegations that some of its IRFs provided inaccurate information to Medicare to maintain their status as an IRF and to earn a higher rate of reimbursement, and that some admissions to its IRFs were not medically necessary.
Read More:
https://www.justice.gov/opa/pr/encompass-health-agrees-pay-48-million-resolve-false-claims-act-allegations-relating-its
$7.2M
In 2014, we represented a physician who worked for a laboratory testing company that had identified fraud in the company’s billing procedures. Our client was one of two Relators in a False Claims Act settlement on behalf of the federal government and various state agencies in the amount of $7.2 Million. Our client received a significant six figure whistleblower award.
$4M
In 2010, we represented relators who had blown the whistle on fraud committed by a contractor to the Department of Defense. Their whistleblower claim had resulted in a recovery of approximately $4 million. We filed a retaliation claim subsequent to the conclusion of the FCA case and our clients recovered a very substantial six figure award.
Approx. $500K
Our firm represented a managerial employee of a trucking company who realized that his employer was committing fraud against the Department of Defense. The company had a contract with DOD to move service members. Managers within the company, who were incentivized to maximize revenues, would actually have service members unwittingly drive their personal vehicles onto weighing stations in order to increase the company’s billings to the government. Our client’s claims resulted in approximately $500,000 being returned to the government, and our client receiving a whistleblower award of approximately $150,000.
In 2009, we represented a client who learned that her employer was engaging in unlawful off-label marketing of a drug that was only approved for use in a diagnostic process. The company had begun to market the drug for use in a therapeutic process which was not approved by the FDA. The case resulted in a significant recovery for the government agencies involved and a substantial whistleblower award for our client.
$400K
In 2015, we filed a False Claims Act complaint on behalf of a physician and a medical office manager against several healthcare concerns. The claims alleged that a physician employed by those concerns had falsely diagnosed lumps and masses in women’s breasts in order to increase billing to federal and state agencies. The claim resulted in a $400,000 settlement and our clients receiving a significant six figure whistleblower award.
Confidential Case Evaluation
Contacting the firm is free and confidential. We understand the unique challenges of whistleblower representation and are ready to discuss your case. Please contact us anytime.
With our recognized leadership in applying legal service and technology innovation, we deliver commercial advantage to clients.
Whistleblower Practice Group
OFFICE: 12350 Jefferson Ave.#300
Newport News, VA 23602
HOURS OF OPERATION: Monday Through Friday: 8:00AM to 6:00PM
TEL: (800) 898-5192
FAX: +757-223-4518
DRIVING DIRECTIONS: Our office is conveniently located in Newport News, VA, near the Patrick Henry Mall. Take HWY 64 to head south on Jefferson Ave. U-Turn on Freedom Way, and our office will be located on the right.